On analysis of longitudinal clinical trials with missing data using reference-based imputation

被引:44
|
作者
Liu, G. Frank [1 ]
Pang, Lei [1 ]
机构
[1] Merck Res Labs, Late Dev Clin Biostat, 351 N Sumneytown Pike,UG1CD 44, N Wales, PA 19454 USA
关键词
Bayesian MCMC; longitudinal clinical trial; missing data; reference-based imputation; sensitivity analysis; MULTIPLE-IMPUTATION;
D O I
10.1080/10543406.2015.1094810
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Reference-based imputation (RBI) methods have been proposed as sensitivity analyses for longitudinal clinical trials with missing data. The RBI methods multiply impute the missing data in treatment group based on an imputation model built using data from the reference (control) group. The RBI will yield a conservative treatment effect estimate as compared to the estimate obtained from multiple imputation (MI) under missing at random (MAR). However, the RBI analysis based on the regular MI approach can be overly conservative because it not only applies discount to treatment effect estimate but also posts penalty on the variance estimate. In this article, we investigate the statistical properties of RBI methods, and propose approaches to derive accurate variance estimates using both frequentist and Bayesian methods for the RBI analysis. Results from simulation studies and applications to longitudinal clinical trial datasets are presented.
引用
收藏
页码:924 / 936
页数:13
相关论文
共 50 条
  • [41] A Likelihood-Based Approach for the Analysis of Longitudinal Clinical Trials with Return-to-Baseline Imputation
    Yilong Zhang
    Gregory Golm
    Guanghan Liu
    [J]. Statistics in Biosciences, 2020, 12 : 23 - 36
  • [42] A Likelihood-Based Approach for the Analysis of Longitudinal Clinical Trials with Return-to-Baseline Imputation
    Zhang, Yilong
    Golm, Gregory
    Liu, Guanghan
    [J]. STATISTICS IN BIOSCIENCES, 2020, 12 (01) : 23 - 36
  • [43] Reference-based sensitivity analysis for time-to-event data
    Atkinson, Andrew
    Kenward, Michael G.
    Clayton, Tim
    Carpenter, James R.
    [J]. PHARMACEUTICAL STATISTICS, 2019, 18 (06) : 645 - 658
  • [44] A wide range of missing imputation approaches in longitudinal data: a simulation study and real data analysis
    Mina Jahangiri
    Anoshirvan Kazemnejad
    Keith S. Goldfeld
    Maryam S. Daneshpour
    Shayan Mostafaei
    Davood Khalili
    Mohammad Reza Moghadas
    Mahdi Akbarzadeh
    [J]. BMC Medical Research Methodology, 23
  • [45] A wide range of missing imputation approaches in longitudinal data: a simulation study and real data analysis
    Jahangiri, Mina
    Kazemnejad, Anoshirvan
    Goldfeld, Keith S.
    Daneshpour, Maryam S.
    Mostafaei, Shayan
    Khalili, Davood
    Moghadas, Mohammad Reza
    Akbarzadeh, Mahdi
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
  • [46] A tutorial for handling suspected missing not at random data in longitudinal clinical trials
    Peugh, James
    Toland, Michael
    Harrison, Heather
    [J]. QUANTITATIVE METHODS FOR PSYCHOLOGY, 2023, 19 (04): : 347 - 367
  • [47] Missing Data in Longitudinal Clinical Trials Part A: Design and Conceptual Issues
    Lavori, Philip W.
    Brown, C. Hendricks
    Duan, Naihua
    Gibbons, Robert D.
    Greenhouse, Joel
    [J]. PSYCHIATRIC ANNALS, 2008, 38 (12) : 784 - 792
  • [48] Assessing and interpreting treatment effects in longitudinal clinical trials with missing data
    Mallinckrodt, CH
    Sanger, TM
    Dubé, S
    DeBrota, DJ
    Molenberghs, G
    Carroll, RJ
    Potter, WZ
    Tollefson, GD
    [J]. BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 754 - 760
  • [49] Multiple imputation for ordinal longitudinal data with monotone missing data patterns
    Kombo, A. Y.
    Mwambi, H.
    Molenberghs, G.
    [J]. JOURNAL OF APPLIED STATISTICS, 2017, 44 (02) : 270 - 287
  • [50] Modified reference based imputation and tipping point analysis in the presence of missing data due to COVID-19
    Jin, Man
    Liu, Ran
    Robieson, Weining
    [J]. CONTEMPORARY CLINICAL TRIALS, 2021, 110